Kalkine Media -
Summary
- Healthcare technology companies are involved in the R&D work that goes into developing medicines and other healthcare solutions.
- Bausch Health (TSX:BHC) reported a total revenue of US$ 1.944 billion for Q1 2023.
- Cipher Pharmaceuticals reported total revenue of US$ 4.9 million in Q1 2023.
The healthcare technology sub-sector includes companies that are involved in the R&D work that goes into developing medicines and other healthcare solutions. These companies may sometimes be well-recognized names and industry leaders, making them companies with stable profit flows.
ALSO READ: GWO & IAG (LON:ICAG): Two insurance stocks to watch in June
BHC and CPH are two such healthcare technology stocks that investors can examine this month.
Bausch Health Companies Inc. (TSX: BHC)
BHCFor the March 2023 quarter, Bausch reported total revenue of US$ 1.944 billion, compared to a total revenue of US$ 2.193 billion in the December 2022 quarter. The operating income for the quarter was US$ 188 million, while the EBITDA was US$ 495 million. Bausch’s operating cash flow for the March 2023 quarter was US$ 27 million.
Image source: ©2023 Kalkine®; Data source: Company Reports
Across the company’s five segments, Bausch reported revenues of US$ 931 million in its Bausch + Lomb segment in F1 2023. This marked an increase of US$ 42 million over the first quarter of 2022.
ALSO READ: L & MRU: Two consumer stocks to watch
Cipher Pharmaceuticals Inc. (TSX: CPH)
Cipher reported total revenue of US$ 4.9 million in Q1 2023, compared to US$ 5.4 million in Q1 2022. For this quarter, the company reported adjusted EBITDA of US$ 3.2 million in Q1 2023, marking an increase of 3%.
Image source: ©2023 Kalkine®; Data source: Company Reports
Cipher’s net income was US$ 2.7 million or US$ 0.10 per diluted share in Q1 2023. While in Q1 2022, the company’s net income was US$ 2.1 million or US$ 0.08 per diluted share. Cipher’s cash position by the end of the quarter was US$ 33.4 million, with no debt. Additionally, the cash from operating activities in Q1 2023 was US$ 4.7 million.